Aarkstore - Age Related Macular Degeneration - Pipeline Review, H2 2014 - PowerPoint PPT Presentation

View by Category
About This Presentation
Title:

Aarkstore - Age Related Macular Degeneration - Pipeline Review, H2 2014

Description:

"Age Related Macular Degeneration - Pipeline Review, H2 2014"report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. – PowerPoint PPT presentation

Number of Views:37

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Aarkstore - Age Related Macular Degeneration - Pipeline Review, H2 2014


1
Age Related Macular Degeneration - Pipeline
Review, H2 2014
Category Pharmaceuticals Healthcare
  • Browse Complete Report -
  • http//www.aarkstore.com/pharmaceuticals-healthcar
    e/63082/age-related-macular-degeneration-pipeline-
    review

2
Age Related Macular Degeneration - Pipeline
Review, H2 2014
3
Summary
  • Global Markets Directs, Age Related Macular
    Degeneration - Pipeline Review, H2 2014,
    provides an overview of the Age Related Macular
    Degenerations therapeutic pipeline.This report
    provides comprehensive information on the
    therapeutic development for Age Related Macular
    Degeneration, complete with comparative analysis
    at various stages, therapeutics assessment by
    drug target, mechanism of action (MoA), route of
    administration (RoA) and molecule type, along
    with latest updates, and featured news and press
    releases. It also reviews key players involved in
    the therapeutic development for Age Related
    Macular Degeneration and special features on
    late-stage and discontinued projects.
  • Global Markets Directs report features
    investigational drugs from across globe covering
    over 20 therapy areas and nearly 3,000
    indications. The report is built using data and
    information sourced from Global Markets Directs
    proprietary databases, Company/University
    websites, SEC filings, investor presentations and
    featured press releases from company/university
    sites and industry-specific third party sources,
    put together by Global Markets Directs team.

4
Summary
  • Drug profiles/records featured in the report
    undergoes periodic updation following a stringent
    set of processes that ensures that all the
    profiles are updated with the latest set of
    information. Additionally, processes including
    live news deals tracking, browser based
    alert-box and clinical trials registries tracking
    ensure that the most recent developments are
    captured on a real time basis.The report
    enhances decision making capabilities and help to
    create effective counter strategies to gain
    competitive advantage. It strengthens RD
    pipelines by identifying new targets and MOAs to
    produce first-in-class and best-in-class
    products.Note Certain sections in the report
    may be removed or altered based on the
    availability and relevance of data for the
    indicated disease.

5
Scope
  • - The report provides a snapshot of the global
    therapeutic landscape of Age Related Macular
    Degeneration- The report reviews key pipeline
    products under drug profile section which
    includes, product description, MoA and RD brief,
    licensing and collaboration details other
    developmental activities - The report reviews
    key players involved in the therapeutics
    development for Age Related Macular Degeneration
    and enlists all their major and minor projects-
    The report summarizes all the dormant and
    discontinued pipeline projects - A review of the
    Age Related Macular Degeneration products under
    development by companies and universities/research
    institutes based on information derived from
    company and industry-specific sources- Pipeline
    products coverage based on various stages of
    development ranging from pre-registration till
    discovery and undisclosed stages- A detailed
    assessment of monotherapy and combination therapy
    pipeline projects- Coverage of the Age Related
    Macular Degeneration pipeline on the basis of
    target, MoA, route of administration and molecule
    type- Latest news and deals relating related to
    pipeline products

6
Reasons to buy
  • - Provides strategically significant competitor
    information, analysis, and insights to formulate
    effective RD development strategies- Identify
    emerging players with potentially strong product
    portfolio and create effective counter-strategies
    to gain competitive advantage- Develop strategic
    initiatives by understanding the focus areas of
    leading companies- Identify and understand
    important and diverse types of therapeutics under
    development for Age Related Macular
    Degeneration- Plan mergers and acquisitions
    effectively by identifying key players of the
    most promising pipeline- Devise corrective
    measures for pipeline projects by understanding
    Age Related Macular Degeneration pipeline depth
    and focus of Indication therapeutics- Develop
    and design in-licensing and out-licensing
    strategies by identifying prospective partners
    with the most attractive projects to enhance and
    expand business potential and scope- Modify the
    therapeutic portfolio by identifying discontinued
    projects and understanding the factors that drove
    them from pipeline  

7
Table of Content
List of Tables 7List of Figures 9Introduction
10Global Markets Direct Report Coverage 10Age
Related Macular Degeneration Overview
11Therapeutics Development 12Pipeline Products
for Age Related Macular Degeneration - Overview
12Pipeline Products for Age Related Macular
Degeneration - Comparative Analysis 13Age
Related Macular Degeneration - Therapeutics under
Development by Companies 14Age Related Macular
Degeneration - Therapeutics under Investigation
by Universities/Institutes 20Age Related Macular
Degeneration - Pipeline Products Glance 22
8
Table of Content
Clinical Stage Products 22Early Stage Products
23Unknown Stage Products 24Age Related Macular
Degeneration - Products under Development by
Companies 25Age Related Macular Degeneration -
Products under Investigation by
Universities/Institutes 30Age Related Macular
Degeneration - Companies Involved in Therapeutics
Development 31Advanced Cell Technology, Inc.
31Alcon, Inc. 32Alkeus Pharmaceuticals, Inc.
33Allergan, Inc. 34AlphaMab Co., Ltd 35Amarna
Therapeutics B.V. 36AngioGenex, Inc. 37Angstrom
Pharmaceuticals, Inc. 38Aprogen, Inc. 39
9
List Of Tables
  • Number of Products under Development for Age
    Related Macular Degeneration, H2 2014 18Number
    of Products under Development for Age Related
    Macular Degeneration - Comparative Analysis, H2
    2014 19Number of Products under Development by
    Companies, H2 2014 21Number of Products under
    Development by Companies, H2 2014 (Contd..1)
    22Number of Products under Development by
    Companies, H2 2014 (Contd..2) 23Number of
    Products under Development by Companies, H2 2014
    (Contd..3) 24Number of Products under
    Development by Companies, H2 2014 (Contd..4)
    25Number of Products under Investigation by
    Universities/Institutes, H2 2014 27Comparative
    Analysis by Clinical Stage Development, H2 2014
    28Comparative Analysis by Early Stage
    Development, H2 2014 29

10
List Of Tables
  • Comparative Analysis by Unknown Stage
    Development, H2 2014 30Products under
    Development by Companies, H2 2014 31Products
    under Development by Companies, H2 2014
    (Contd..1) 32Products under Development by
    Companies, H2 2014 (Contd..2) 33Products under
    Development by Companies, H2 2014 (Contd..3)
    34Products under Development by Companies, H2
    2014 (Contd..4) 35Products under Investigation
    by Universities/Institutes, H2 2014 36Age
    Related Macular Degeneration - Pipeline by
    Advanced Cell Technology, Inc., H2 2014 37Age
    Related Macular Degeneration - Pipeline by Alcon,
    Inc., H2 2014 38Age Related Macular Degeneration
    - Pipeline by Alkeus Pharmaceuticals, Inc., H2
    2014 39Age Related Macular Degeneration -
    Pipeline by Allergan, Inc., H2 2014 40Age
    Related Macular Degeneration - Pipeline by
    AlphaMab Co., Ltd, H2 2014 41

11
List of Figures
  • Number of Products under Development for Age
    Related Macular Degeneration, H2 2014 18Number
    of Products under Development for Age Related
    Macular Degeneration - Comparative Analysis, H2
    2014 19Number of Products under Development by
    Companies, H2 2014 20Number of Products under
    Investigation by Universities/Institutes, H2 2014
    26Comparative Analysis by Clinical Stage
    Development, H2 2014 28Comparative Analysis by
    Early Stage Products, H2 2014 29Assessment by
    Monotherapy Products, H2 2014 90Number of
    Products by Top 10 Targets, H2 2014 91Number of
    Products by Stage and Top 10 Targets, H2 2014
    91Number of Products by Top 10 Mechanism of
    Actions, H2 2014 94Number of Products by Stage
    and Top 10 Mechanism of Actions, H2 2014
    94Number of Products by Top 10 Routes of
    Administration, H2 2014 96

12
Related Reports
  • Global Neurosurgery Market 2015-2019
  • BrainStorm Cell Therapeutics Inc. (BCLI) -
    Financial and Strategic SWOT Analysis Review
  • Ampio Pharmaceuticals, Inc. (AMPE) - Financial
    and Strategic SWOT Analysis Review
  • MiMedx Group, Inc (MDXG) - Financial and
    Strategic SWOT Analysis Review
  • Threshold Pharmaceuticals, Inc. (THLD) -
    Financial and Strategic SWOT Analysis Review

13
Related Reports
  • MEI Pharma, Inc. (MEIP) - Financial and Strategic
    SWOT Analysis Review
  • Titan Pharmaceuticals, Inc. (TTNP) - Financial
    and Strategic SWOT Analysis Review
  • RedHill Biopharma Ltd. (RDHL) - Financial and
    Strategic SWOT Analysis Review
  • Pharmaceuticals Healthcare Market Research
    Reports

14
  • Age Related Macular Degeneration - Pipeline
    Review, H2 2014
  • Published Oct 2014 252 Pages
  • Age Related Macular Degeneration - Pipeline
    Review, H2 2014 report features investigational
    drugs from across globe covering over 20 therapy
    areas and nearly 3,000 indications.
    Price

Format Price
PDF 2000
Site Licence 4000
Enterprise Wide Licence 6000
15
Contact Us
Office Office No. - 809, 8th Floor,B-Wing,
Mahaavir Icon, Plot No.- 89 90,
Sector-15,CBD-Belapur, Navi Mumbai
400614, Maharashtra, India. Telefax No 91 22
4127 6660 24/7 Online Support 91
9987295242 General Inquiries 91 - 22 2756 4953
  • You Can Visit http//www.aarkstore.com
  • OR Mail us at contact_at_aarkstore.com
  • Blog
  • http//www.aarkstore.com/blog/
  • Conference
  • http//conference.aarkstore.com/
  • News
  • http//www.aarkstore.com/news
About PowerShow.com